Anti-SARS-CoV-2 Spike S1 (RBD) Neutralizing Antibody (V3S-0623-XY132) (CAT#: V3S-0623-XY132)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody F61 is a human mAb specific for SARS-CoV-2 Spike S1 protein. It exhibits high-affinity binding to Delta-RBD, Omicron-RBD-BA.1 and Omicron RBD-BA.2. The KD values to Delta-RBD, Omicron-RBDBA.1 and Omicron-RBD-BA.2 by the antibody were ~3.89 pM, ~5.03 nM and ~93.3 pM, respectively. It was highly potent in neutralizing SARS-CoV-2 WT pseudovirus with half-maximal inhibitory concentration (IC50) of 6 ng/mL. It exhibited high potency and broad neutralization against Alpha, Beta, Delta and Omicron, even its binding to Omicron-RBD-BA.1 was significantly reduced (~1000-fold) compared to WT-RBD.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Cross Reactivity Delta, Omicron BA.1 and BA.2
Epitope Receptor-binding domain (RBD)
Affinity 3.89 pM (Delta), 5.03 nM (Omicron) and 93.3 pM (Omicron)
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA, Neut
Application Notes F61 was highly potent in neutralizing SARS-CoV-2 WT pseudovirus with half-maximal inhibitory concentration (IC50) of 6 ng/mL.
ELISA plates were coated with SARS-CoV-2 protein including WT-S1, WT-NTD, WT-RBD, Delta-S1, Delta_x005F_x0002_RBD and Omicron-RBD at 4°C overnight. Following washing with PBST, serial dilutions of testing antibodies starting at 5 μg/mL were added to each well and incubated at 37°C for 30 min. After washing with PBST, HRP-conjugated anti-human IgG Fc specific antibody was added at the dilution of 1:2000 and incubated at 37°C for 30 min. The absorbance was detected at 450 nm.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Western Blot Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry